In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
AGEN BioMedical and Biosite enter into license for D-dimer
Agenix secures diagnostic licenses from Abbott Laboratories
Agenix sale of Milton Pharmaceuticals settles
Termination of Peptech and Agenix merger
Agenix sells Milton Pharmaceuticals, focuses on Molecular Imaging
Agenix wins $1.13 million AusIndustry R&D START grant for ThromboView®
Peptech and Agenix merger to create Australia's premier biotech company
Agenix formalizes secondary distribution arrangements for anti-HBV drug
CombiMatrix Launches New Prostate Cancer Array-Based Diagnostic Test
ACRUX REPORTS COMPLETION OF SUB-LICENSE OF EVAMIST RIGHTS FROM VIVUS TO KV PHARMACEUTICAL